MyFinsight
Home
Blog
About
Back
Income Statement
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)
source: myfinsight.com
Comprehensive loss
-$44,904K
(-4.95%↓ Y/Y)
Interest income, net
$2,184K
(-33.33%↓ Y/Y)
Other income, net
$398K
(-66.27%↓ Y/Y)
Net loss
-$44,755K
(-4.85%↓ Y/Y)
Net unrealized gain
on marketable...
-$149K
(-47.52%↓ Y/Y)
Total other income,
net
$2,582K
(-42.06%↓ Y/Y)
Loss from operations
-$47,337K
(-0.42%↓ Y/Y)
Revenue
$4K
(-50.00%↓ Y/Y)
Total operating
expenses
$47,341K
(0.41%↑ Y/Y)
Other operating
(income) loss, net
$1,759K
(265.63%↑ Y/Y)
Research and development
$39,524K
(13.39%↑ Y/Y)
General and
administrative
$9,576K
(-2.15%↓ Y/Y)
Back